A negative correlation between insulin-like peptide 3 and bisphenol A in human cord blood suggests an effect of endocrine disruptors on testicular descent during fetal development

Human Reproduction

Volumn 30, Issue 2, 2015, Pages 447-453

  Chevalier, Nicolas ^a,b   Brucker Davis, Françoise ^a,b   Lahlou, Najiba ^c   Coquillard, Patrick ^d   Pugeat, Michel ^e   Pacini, Patricia ^f   Panaïa Ferrari, Patricia ^g   Wagner Mahler, Kathy ^g   Fénichel, Patrick ^a,b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^c Institut Cochin   (France)

^d CNRS   (France)

^e CarMeN   (France)

^f Laboratoire de L'Environnement de la Ville de Nice ^*  (France)

^g UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

Bisphenol A; Cryptorchidism; Fetal exposure to endocrine disruptors; Human testicular descent; Insulin like peptide 3

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,2',4,4',5,5' HEXACHLOROBIPHENYL; 4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; INSULIN LIKE PEPTIDE 3; MONOBUTYL PHTHALATE; PEPTIDE HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; BIOLOGICAL MARKER; INSULIN; LEYDIG INSULIN-LIKE PROTEIN; PROTEIN;

ARTICLE; BREAST MILK; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTORCHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS DEVELOPMENT; FRANCE; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEYDIG CELL; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; NEWBORN; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; TANDEM MASS SPECTROMETRY; TESTIS DESCENT; TESTOSTERONE BLOOD LEVEL; UMBILICAL CORD BLOOD; ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; COHORT ANALYSIS; CRYPTORCHIDISM; DRUG EFFECTS; EMBRYOLOGY; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS BLOOD; MULTICENTER STUDY; NEWBORN SCREENING; PREGNANCY; RISK; SECRETION (PROCESS); TESTIS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CRYPTORCHIDISM; ENDOCRINE DISRUPTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; FRANCE; HUMANS; INFANT, NEWBORN; INSULIN; LEYDIG CELLS; MALE; MATERNAL EXPOSURE; NEONATAL SCREENING; PREGNANCY; PROSPECTIVE STUDIES; PROTEINS; RADIOIMMUNOASSAY; RISK; TESTIS;

EID: 84926391373     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu340     Document Type: Article

References (60)

1. Albert O, Jegou B. A critical assessment of endocrine susceptibility of the human testis to phthalates from fetal life to adulthood. Hum Reprod Update 2014;20:231-249.
2. Anand-Ivell R, Ivell R. Insulin-like factor 3 as a monitor of endocrine disruption. Reproduction 2014;147:87-95.
3. Balakrishnan B, Henare K, Thorstensen EB, Pomnampalam AP, Mitchell MD. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 2010;202:393-397.
4. Bay K, Anderson AM. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders. Int J Androl 2011;34:97-109.
5. Bay K, Virtanen HE, Hartung S, Ivell R, Main KM, Skakkebaek NE, Andersson AM. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, post-natal hypothalamic-pituitary-gonadal axis activation and cryptorchidism. J Clin Endocrinol Metab 2007; 92:40206-40227.
6. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264-1269.
7. Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009;117:1053-1058.
8. Brucker-Davis F,Wagner-Mahler K, Delattre I, Ducot B, Ferrari P, Bongain A, Kurzenne JY, Mas JC, Fénichel P. Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, assessed by colostrum concentrations. Hum Reprod 2008;23:1708-1718.
9. Cabrol S, Ross JL, Fennoy I, Bouvatier C, Roger M, Lahlou N. Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels. J Clin Endocrinol Metab 2011;96:E746-E753.
10. Calafat AM, Koch HM, Swan SH, Hauser R, Goldman LR, Lanphear BP, Longnecker MP, Rudel RA, Teitelbaum SL, Whyatt RM et al. Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res 2013;15:403.
11. Chevalier N, Bouskine A, Fenichel P. Bisphenol A promotes testicular seminoma cell proliferation through GPER/GPR30. Int J Cancer 2012a; 130:241-242.
12. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, Chevallier D, Fénichel P. GPR30, the non classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 2012b;7:e34672.
13. Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth MEJ. Apparent doubling of frequency of undescended testis in England and Wales in 1962-1981. Lancet 1984;2:330-332.
14. Cook MB, Akre O, Forman D, Madigan MP, Riciardi I, McGlynn KA. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer. Int J Epidemiol 2010;39:1605-1618.
15. CoughtrieMW, Burchell B, Leakey JE, Hume R. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol Pharmacol 1988;34:729-735.
16. Damgaard IN, Skakkebaeck NE, Toppari J, Virtanen HE, Shen H, Schramm KW. Persistent pesticides in human breastmilk and cryptorchidism. Environ Health Perspect 2006;114:1133-1138.
17. Dekant W, Vö lkel W. Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. Toxicol Appl Pharmacol 2008;228:114-134.
18. Desdoits-Lethimonier C, Albert O, Le Bizec B, Perdu E, Zalko D, Courant F, Lesné L, Guille F, Dejucq-Rainsford N, Jebou B. Human testis steroidogenesis is inhibited by phthalates. HumReprod 2012;27:1451-1459.
19. Emmen JM, McLuskey A, Adham IM, Engel W, Grootegoed JA, Brinkmann AO. Hormonal control of gubernaculum development during testis descent: gubernaculum out growth in vitro requires both insulin-like factor and androgen. Endocrinology. 2000;141:4720-4727.
20. Feng S, Coressis VK, Hwang A, Hardy B, Koh CJ, Bogatcheva NV, Agoulnik AI. Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism. Urology 2004;64:1032-1036.
21. Feng S, Bogatcheva NV, Truong A, Korchin B, Bishop CE, Klonisch T, Agoulnik IU, Agoulnik AI. Developmental expression and gene regulation of insulin-like peptide 3 receptor RXFP2 in mouse male reproductive organs. Biol Reprod 2007;77:671-680.
22. Fénichel P, Déchaux H, Harthe C, Gal J, Ferrari P, Pacini P,Wagner-mahlerC, Pugeat M, Brucker-Davis F. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes.Hum Reprod 2012;27:983-990.
23. Fénichel P, Lahlou N, Coquillard P, Panaïa-Ferrari P, Wagner-Mahler K, Brucker-Davis F. Cord blood insulin-like peptide 3 (INSL3) but not testosterone is reduced in idiopathic cryptorchidism. Clin Endocrinol 2014; May 15. doi: 10.1111/cen.12500 (epub ahead of print).
24. Ferlin A, Zucarello D, Zucarello B, Chirico MR,ZanonGF, Foresta C. Genetic alterations associated with cryptorchidism. JAMA 2008;300:2271-2276.
25. Foresta C, Zucarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29:560-580.
26. Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, Veeramachaneni DN, Wilson V, Price M, Hotchkiss A et al. Effects of environmental anti-androgens on reproductive development in experimental animals. Hum Reprod Update 2001;7:248-264.
27. Hack WW, Meijer RW, Bos SD, Haasnoot K. A new clinical classification for undescended testis. Scand J Urol Nephrol 2003;37:43-47.
28. Hadziselimovic F. Cryptorchidism: its impacton male infertility. Eur Urol 2002; 41:121-123.
29. Hirsch HJ, Eldar-Geva T, Gross-Tsur V, Benarroch F, Roger M, Lahlou N. Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy to adulthood. J Clin Endocrinol Metab 2013;98:E135-E143.
30. Hudson JM, Southwell BR, Li R, Ismail K, Harisis G, Chen N. The regulation of testicular descent and the effects of cryptorchidism. Endocr Rev 2013; 34:725-752.
31. Hughes IA, Acerini CL. Factors controlling testis descent. Eur J Endocrinol 2008;2159:975-982.
32. Kaddar N, Bendridi N, Harthe C, de Ravel MR, Bienvenu AL, Cuilleron CY, Mappus E, Pugeat M, Déchaud H. Development of a radioimmunoassay for the measurement of bisphenol A in biological samples. Anal Chim Acta 2009;645:1-4.
33. Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di(2-ethylhexyl phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 2005;79:367-376.
34. Koch HM, Kolossa-Gehring M, Schröter-Kermani C, Angerer J, Brüning T. Bisphenol A in 24 h urine and plasma samples of the German environmental specimen bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol 2012;22:610-616.
35. Lague E, Tremblay JJ. Antagonistic effects of testosterone and the endocrine disruptor mono- (2)-ethylhexyl phthalate on INSL3 transcription in Leydig cells. Endocrinology 2008;149:4688-4694.
36. Lague E, Tremblay H. Estradiol represses insulin-like peptide 3 expression and promoter activity in MA-10 Leydig cells. Toxicology 2009;258:101-105.
37. Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Main KM, Skakkebaeck NE, Jorgensen N, Kranich SK, Andersson AM. Temporal variability in urinary excretion of bisphenol A and seven other phenols in spot, morning and 24-h urine samples. Environ Res 2013;126:164-170.
38. Lee HJ, Chattopadhyay S, Gong EY, Ahn RS, Lee K. Anti-androgenic effects of bisphenolAand nonylphenol on the function of androgen receptor. Toxicol Sci 2003;75:40-46.
39. Main KM, Skakkebaeck NE,Toppari J. Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection. Endocr Rev 2009; 14:167-173.
40. Matsumoto J, Yokota H, Yuasa A. Developmental increases in rat hepatic microsomal UDP-glucuronyl-transferase activities toward xenoestrogens and decreases during pregnancy.EnvironHealthPerspect 2002;110:193-196.
41. Matthews JB, Twomey K, Zacharewski TR. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors a and b. Chem Res Toxicol 2001;14:149-157.
42. McKinnell C, Sharpe RM, Mahood K, Hallmark N, Scott H, Ivell R, Staub C, Jégou B, Haag F, Koch-Nolte F et al. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-butyl) phthalate. Endocrinology 2005;146:4536-4544.
43. Mielke H, Gundert-Remy U. Bisphenol A levels in blood depend on age and exposure. Toxicol Lett 2009;190:32-40.
44. Nef S, Parada LF. Cryptorchidism in mice mutant for INSLl3. Nat Genet 1999; 22:295-299.
45. Nef S, Shipman T, Parada LF. Molecular basis for estrogen-induced cryptorchidism. Dev Biol 2000;224:354-361.
46. N'Tumba-BynT,MoisonD, Lacroix M, LecueuilC, Lesage L, Prud'hommeSM, Pozzi-Gaudin S, Frydman R, Benachi A, Livera G et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat andmouse fetal Leydig cell function. PLoS One 2012;7:1-10.
47. Palmer JR, Herbst AL, Noller KL, Boggs DA, Troisi R, Titus-Ernstoff L, Hatch EE, Wise LA, Strohsnitter WC, Hoover RN. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health 2009;8:37-42.
48. Schö nfelder G, WittfohtW, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002;110:703-707.
49. Sharpe RM. Is it time to end concerns over the estrogenic effects of bisphenol A? Toxicol Sci 2010;114:1-4.
50. Shono T, Shima Y, Kondo T, Suita S. In utero exposure to mono-n-butyl phthalate impairs INSL3 gene expression and the transabdominal phase of testicular descent in fetal rats. J Pediatr Surg 2005;40:1861-1864.
51. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogenrelated receptor gamma (ERRg) with high constitutive activity. Toxicol Lett 2006;167:95-105.
52. Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Hum Reprod Update 2001;7:282-286.
53. Vandenberg LN,Chahoud I,Heindel JJ, PadmanabhanV, Paumgarten. Urinary, circulating, and tissue bio-monitoring studies, indicatewidespread exposure to bisphenol A. Environ Health Perspect 2010;118:1055-1070.
54. Virtanen HE, Adamson A. Cryptorchidism and endocrine disrupting chemicals. Mol Cell Endocrinol 2012;355:208-220.
55. Virtanen HE, Cortes D, Rajpert-De Meyts E, Ritzén EM, Nordenskjö ld A, Skakkebaek NE, Toppari J. Development and descent of the testis in relation to cryptorchidism. Acta Paediatr 2007;96:622-627.
56. Wagner-Mahler K, Kurzenne JY, Delattre I, Bérard E, Mas JC, Bornebush L, Tommasi C, Boda-Buccino M, Ducot B, Boullé C et al. Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from Nice area, France. Int J Androl 2011;34: 499-510.
57. Yeh X, Zhou X,Wong LY, Calafat AM. Concentrations of bisphenol A and seven other phenols in pooled sera from 3-11 year old children: 2001-2002 National Health and Nutrition Examination Survey. Environ Sci Technol 2012;46:12664-12671.
58. Yuan FP, Li X, Lin J, Schwabe C, Büllesbach EE, Rao CV, Lei ZM. The role of RXFP2 in mediating androgen-induced inguino-scrotal testis descent in LH receptor knockout mice. Reproduction 2010;139:759-769.
59. Zhang T, Sun H, Kannan K. Blood and urinary bisphenol A concentrations in children, adults, and pregnant women from China: partitioning between blood and urine and maternal and fetal cord blood. Environ Sci Technol 2013;47:4686-4694.
60. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM. Targeted disruption of the INSL3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999;13:681-691.